Marlborough

Marlborough-based Boston Scientific Corp. has completed its acquisition of American Medical Systems' (AMS) Men's Health and Prostate Health businesses for $1.6 billion.

A 2.3-percent tax doesn't sound like much, but taking it directly off the top of medical device companies' sales could have widespread impacts on businesses large and small, industry experts say.

Solomon Pond Mall in Marlborough and the Auburn Mall are among 12 shopping sites in Massachusetts and New Hampshire that have added charging stations for drivers of electric vehicles, the malls' owner said.

Marlborough-based Boston Scientific saw its operational revenue and profits rise in the second quarter, the company reported Thursday. The results are at the upper end of the company's guidance range.

On the heels of news that global pharmaceutical giant Pfizer plans to consolidate its local operations into a 500,000 square foot campus for about 1,000 employees in Cambridge, industry executives gathered Wednesday to discuss the biotech real estate boom and its impact on commercial real estate trends in the state.

ReWalk Robotics, the first company to bring an exoskeleton to market after approval from the U.S. Food and Drug Administration, is celebrating a commercialization milestone that hits close to home today.

Ocata Therapeutics of Marlborough has secured another patent for its technology aimed at treating some forms of macular degeneration, the company announced last week.

In May, Marlborough-based Boston Scientific Corp. lost a $100 million verdict in a case over its transvaginal...

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, ATryn, will soon receive FDA approval for the treatment of preeclampsia.

ReWalk Robotics, the Marlborough-based maker of exoskeleton systems for paraplegics, released the sixth-generation version of its exoskeleton this week.